A 3-cohort Randomized Study Evaluating the Role of New Immunotherapeutic Agents and of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Frontline Therapy of Adults With Acute Lymphoblastic Leukemia
PHASE2
Adult acute lymphoblastic leukemia (ALL) includes Ph-positive (Phpos) ALL, ...
Dose-Escalation Study of Ponatinib, a FLT3 Inhibitor, With and Without Combination of 5-Azacytidine, in Patients With FLT3-Mutated Acute Myeloid Leukemia (AML)
PHASE1
The goal of Part 1 of this clinical research study is to learn if ponatinib...
A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)
PHASE1
The purpose of this study is to learn more about LP-118 (an experimental dr...
Status
Recruiting
Location
University of Chicago Medicine Comprehensive Cancer Center